HRTX

Heron Therapeutics, Inc.

3.45 USD
+0.18 (+5.50%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Heron Therapeutics, Inc. stock is up 48.71% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 36.36% of the previous 10 May’s closed higher than April. In the last 1 Unusual Options Trades, there were 1 CALL. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
23 Apr 16:05 20 Sep, 2024 5.00 CALL 1000 112

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy.

  • Needham
    Thu May 16, 05:27
    buy
    confirm
  • Needham
    Wed May 8, 05:34
    buy
    confirm